Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Piperazinyl-sulfonamide derivatives useful in the treatment of GPR38 receptor mediated diseases

Piperazinyl-sulfonamide derivatives useful in the treatment of GPR38 receptor mediated diseases

US Patent 7964597 · Granted Jun 21, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and the2022
2,3-dihydrobenzohurans as bromodomain inhibitors2022
Benzofuran derivatives and their use as bromodomain inhibitors2022
Pyrazole derivatives as bromodomain inhibitors2021
Pyridyl derivatives as bromodomain inhibitors2021
Pyridinone dicarboxamide for use as bromodomain inhibitors2021
Pyridyl derivatives as bromodomain inhibitors2020
Pyridine dicarboxamide derivatives as bromodomain inhibitors2020
Benzo[b]furans as bromodomain inhibitors2020
2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and the2020
2-OXO-1,2-dihydropyridine-3,5-dicarboxamide compounds as bromodomain inhibitors2019
Pyridinone dicarboxamide for use as bromodomain inhibitors2019